Skip to search boxSkip to navigationSkip to main content

Overexpression of protein kinase C α and β1 has distinct effects on bovine aortic endothelial cell growth

*Corresponding author for this work
Scholary Output:
Contribution to journal
Article
Peer-review

Open access

Abstract

Protein kinase C (PKC) plays an important role in the mitogenic response of endothelial cells to growth factors. PKC α and β1 are the predominant classical isoforms expressed by bovine aortic endothelial cells (BAECs). The present studies were undertaken to elucidate the effect of PKC α and β1 overexpression in BAEC growth. A series of BAEC lines that stably overexpress the full-length PKC α and β1 cDNA were generated by using a replication-defective recombinant retrovirus. The level of PKC α and β1 cDNA expression was determined by assaying for PKC α and β1 mRNA transcripts. PKC α and β1 protein levels were analysed by Western blotting. Functional analysis of these overexpressing lines was performed by measuring PKC activity and phorbol ester-binding assays. PKC α and B1 overexpression had distinctive effects on BAEC growth and cell-cycle progression. Relative to untransfected BAECs and BAECs transfected with the viral vector alone, BAECs that overproduced PKC a exhibited reduced proliferation in vitro and increased accumulation of cells in the G2/M phase of the cell cycle. Growth inhibition was greater in cell lines overexpressing higher levels of PKC α. Conversely, a 5-fold greater increase in PKC β1 activity promoted BAEC growth and shortened BAEC doubling time, whereas cells with a 2- to 4-fold increase in enzyme activity had growth profiles similar to those of both control groups. These results suggest that PKC α and β1 overexpression has reciprocal effects on BAEC growth.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 589-597 (9 pages)

Journal (Volume, Issue Number)

Cellular Signalling (Volume 10, Issue 8)

Publication milestones

  • Published - 09/1998

Publication status

Published - 09/1998

ISSN

0898-6568

Publication IDs

  • Scopus: 0031725566
  • PubMed: 9794258

Publication metrics

Metrics

SciVal
FWCI
0.19
SciVal
Author count
3
SciVal
citations
11
SciVal
Paper percentile
60
Fractional count
1
Fractional count
0.33
Fractional count
2
Fractional count
0.67
Fractional count
1
Fractional count
1
Scopus
citations

PlumX, opens in new tab

Captures
4
Citation count
11

Funding Details

This work was supported in part by funds from the Department of Veterans Affairs and the Patrick and Catherine Weldon Donaghue Foundation, Hartford, Connecticut (O. R.), and DK-19813 (C. M. I.). We thank Drs. Michael D. Ezekowitz, David Coleman and Fred Wright for their helpful suggestions in the preparation of this manuscript.
FundersFunding number
NIDDK
R01DK019813
VA
-
Patrick and Catherine Weldon Donaghue Medical Research Foundation
-